Alterations of Gut Microbiota and the Brain-Immune-Intestine Axis in Patients With Relapsing-Remitting Multiple Sclerosis After Treatment With Oral Cladribine: Protocol for a Prospective Observational Study.

van Pamelen, Jeske; van Olst, Lynn; Budding, Andries E; de Vries, Helga E; Visser, Leo H

van Pamelen, Jeske; van Olst, Lynn; Budding, Andries E; de Vries, Helga E; Visser, Leo H.

Afiliação

van Pamelen J; Department of Neurology, Elisabeth-TweeSteden Ziekenhuis Hospital, Tilburg, Netherlands.
van Olst L; Department of Molecular Cell Biology and Immunology, MS Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Budding AE; inBiome, Amsterdam, Netherlands.
de Vries HE; Department of Molecular Cell Biology and Immunology, MS Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, Netherlands.
Visser LH; Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, Netherlands.

JMIR Res Protoc ; 9(7): e16162, 2020 07 29.

Article em En | MEDLINE | ID: mdl-32723709